ARDS - Aridis Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARDS is currently covered by 2 analysts with an average price target of $9.71. This is a potential upside of $9.66 (19320%) from yesterday's end of day stock price of $0.05.

Aridis Pharmaceuticals's activity chart (see below) currently has 2 price targets and 6 ratings on display. The stock rating distribution of ARDS is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for ARDS is $1, Lowest price target is $1, average price target is $9.71.

Most recent stock forecast was given by CARL BYRNES from NORTHLAND CAPITAL MARKETS on 23-Nov-2022. First documented stock forecast 10-Sep-2018.

Best performing analysts who are covering ARDS - Aridis Pharmaceuticals:

Louise Chen Carl Byrnes

Currently out of the existing stock ratings of ARDS, 4 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

2

$1.92 (2400.00%)

10

1 years 6 months 3 days ago

0/3 (0%)

$1.1 (122.22%)

Buy

25

$24.93 (35614.29%)

25

4 years 3 months 29 days ago

0/2 (0%)

$18.21 (268.19%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ARDS (Aridis Pharmaceuticals) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ARDS (Aridis Pharmaceuticals) with a proven track record?

LOUISE CHEN

Which analyst has the current lower performing score on ARDS (Aridis Pharmaceuticals) with a proven track record?

CARL BYRNES

Which analyst has the most public recommendations on ARDS (Aridis Pharmaceuticals)?

Louise Chen works at CANTOR FITZGERALD and has 29 price targets and 17 ratings on ARDS

Which analyst is the currently most bullish on ARDS (Aridis Pharmaceuticals)?

Louise Chen with highest potential upside - $24.93

Which analyst is the currently most reserved on ARDS (Aridis Pharmaceuticals)?

Carl Byrnes with lowest potential downside - $1.92

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?